www.torontorehab.com
FREE 57p illustrated REPORT ISSN 1910-6831
$38 million research grant.
Chief Scientist
Prof G.FERNIE PhD PEng
Yearly FREE Research meeting (2010 at Toronto SHERATON HOTEL)
20.11.10
TORONTO: 4th Int.Congress on EARLY ONSET SCOLIOSIS & GROWING SPINE
(ICEOS)Nov.19/20 SHERATON TORONTO HOTEL.
Chairman:La JOLLA,Ca. San Diego Centre for Spinal Disorders, Prof. B.A.AKBARNIA MD(Tehran)
"THE GROWING SPINE" B.A.AKBARNIA,M.YAZICI,G.H.THOMPSON Eds.2010,630 pp,304 illus.,81 in colour. SPRINGER Euro.180. ISBN 978-3-540-85206-3
Interesting comments on Danish Surgeon H.W.SCHEUERMANN (1877-1960) "Juvenile scoliosis" and German Pathologist C.G.SCHMORL (1861-1932) "nodes".
Chairman:La JOLLA,Ca. San Diego Centre for Spinal Disorders, Prof. B.A.AKBARNIA MD(Tehran)
"THE GROWING SPINE" B.A.AKBARNIA,M.YAZICI,G.H.THOMPSON Eds.2010,630 pp,304 illus.,81 in colour. SPRINGER Euro.180. ISBN 978-3-540-85206-3
Interesting comments on Danish Surgeon H.W.SCHEUERMANN (1877-1960) "Juvenile scoliosis" and German Pathologist C.G.SCHMORL (1861-1932) "nodes".
12.11.10
HemaCAM: HORN IMAGING GmbH & FRAUNHOFER IIS.
Performing blood counts automatically
Press Release 10.11.2010
With the HemaCAM, scientists at the Fraunhofer Institute for Integrated Circuits IIS in Erlangen have developed a system that automates the assessment of blood counts and at the same time improves the quality of the findings. In collaboration with Horn Imaging GmbH the device has been approved in accordance with the Medicinal Product Guidelines. “The core idea was to combine a microscope with digital image processing,” explains Dr. Christian Münzemeyer, group manager for medical image processing at IIS. “Whereas existing methods such as flow cytometry are based on physical measuring methods, the HemaCAM imitates humans.” Like a human eye, a camera looks through the microscope. Image processing software automatically analyzes up to eight abnormal blood smears and provides classification suggestions.
The expert describes the operation of the new diagnosis system, which makes working procedures in the laboratory more efficient: “For this we have trained our system with expert knowledge. The background to this is a database in which every cell has been entered manually. Computer algorithms use this database to analyze and pre-sort the recorded cells. Every abnormal cell can be individually documented, enlarged up to 100 times. The MLS in the laboratory only checks the result, verifies and then approves it. The findings are then fed into the laboratory information system, and the laboratory director can send out the findings.”
More than six years of development time were required to transform the idea into a fully operational series product. Since the beginning of October Horn Imaging GmbH HemaCAM has been marketing the microscopy system and installing it in specialist laboratories throughout Europe. Fraunhofer researchers are already working on further improvements, though, and will present these at Medica 2010. Director of the department of image processing and medical engineering Christian Weigand adds: “What is new is that we have now integrated a slide handling system that permits us to automatically evaluate and analyze up to 200 slides. In addition to this a further software component is an analysis support system for the morphology of the red blood count. This can be used to diagnose types of anemia, for example; at the same time the red blood count provides indications of liver or kidney damage, metabolic diseases and deficiency symptoms.”
Press Release 10.11.2010
With the HemaCAM, scientists at the Fraunhofer Institute for Integrated Circuits IIS in Erlangen have developed a system that automates the assessment of blood counts and at the same time improves the quality of the findings. In collaboration with Horn Imaging GmbH the device has been approved in accordance with the Medicinal Product Guidelines. “The core idea was to combine a microscope with digital image processing,” explains Dr. Christian Münzemeyer, group manager for medical image processing at IIS. “Whereas existing methods such as flow cytometry are based on physical measuring methods, the HemaCAM imitates humans.” Like a human eye, a camera looks through the microscope. Image processing software automatically analyzes up to eight abnormal blood smears and provides classification suggestions.
The expert describes the operation of the new diagnosis system, which makes working procedures in the laboratory more efficient: “For this we have trained our system with expert knowledge. The background to this is a database in which every cell has been entered manually. Computer algorithms use this database to analyze and pre-sort the recorded cells. Every abnormal cell can be individually documented, enlarged up to 100 times. The MLS in the laboratory only checks the result, verifies and then approves it. The findings are then fed into the laboratory information system, and the laboratory director can send out the findings.”
More than six years of development time were required to transform the idea into a fully operational series product. Since the beginning of October Horn Imaging GmbH HemaCAM has been marketing the microscopy system and installing it in specialist laboratories throughout Europe. Fraunhofer researchers are already working on further improvements, though, and will present these at Medica 2010. Director of the department of image processing and medical engineering Christian Weigand adds: “What is new is that we have now integrated a slide handling system that permits us to automatically evaluate and analyze up to 200 slides. In addition to this a further software component is an analysis support system for the morphology of the red blood count. This can be used to diagnose types of anemia, for example; at the same time the red blood count provides indications of liver or kidney damage, metabolic diseases and deficiency symptoms.”
1.11.10
TOMOTHERAPY TREATMENT CENTRES: QUEBEC
Hospitalier de l’Université de Montréal (CHUM)
Hôpital Notre-Dame
1560 rue Sherbrooke Est
Montréal, Québec
H2L 4M1
+1 514 890 8254
Go to the Centre Hospitalier de l’Université de Montréal (CHUM)
websiteCentre Universitaire de Santé McGill
1650 Cedar Avenue
Montreal, Quebec
H3G 1A4
+1 514 934 1934
Go to the Centre Universitaire de Santé McGill website.
Hôpital Notre-Dame
1560 rue Sherbrooke Est
Montréal, Québec
H2L 4M1
+1 514 890 8254
Go to the Centre Hospitalier de l’Université de Montréal (CHUM)
websiteCentre Universitaire de Santé McGill
1650 Cedar Avenue
Montreal, Quebec
H3G 1A4
+1 514 934 1934
Go to the Centre Universitaire de Santé McGill website.
TOMOTHERAPY TREATMENT CENTRES: ONTARIO
TomoTherapy® Treatment Centers - Ontario London Regional Cancer Program
790 Commissioners Road East
London, ON N6A 4L6 Canada
+1 519 685 8600
Go to the London Regional Cancer Program website
The Ottawa Hospital Cancer Centre
Integrated Cancer Program
Division of Radiation Oncology
503 Smyth Road
Ottawa, Ontario
Canada K1H 1C4
+1 613 737 7700 x70205
Go to the The Ottawa Hospital Cancer Centre website
Toronto Sunnybrook Regional Cancer Centre
2075 Bayview Avenue
Toronto, Ontario
Canada M4N 3M5
+1 416 480 5000
Go to the Toronto Sunnybrook Regional Cancer Centre website.
790 Commissioners Road East
London, ON N6A 4L6 Canada
+1 519 685 8600
Go to the London Regional Cancer Program website
The Ottawa Hospital Cancer Centre
Integrated Cancer Program
Division of Radiation Oncology
503 Smyth Road
Ottawa, Ontario
Canada K1H 1C4
+1 613 737 7700 x70205
Go to the The Ottawa Hospital Cancer Centre website
Toronto Sunnybrook Regional Cancer Centre
2075 Bayview Avenue
Toronto, Ontario
Canada M4N 3M5
+1 416 480 5000
Go to the Toronto Sunnybrook Regional Cancer Centre website.
25.10.10
VIRTUAL BRAIN: Toronto BAYCREST (Jewish Home for the Aged) KUNIN-LUNENFELD APPLIED RESEARCH UNIT.
October 22, 2010
For Immediate Release
Baycrest’s virtual brain project receives $6.3M from American foundation
Toronto, Canada – The U.S.-based James S. McDonnell Foundation has awarded $6.3 million in new funding over the next three years to an international project led by Baycrest to create the world’s first functional, virtual brain.
Dr. Randy McIntosh, project leader.
Dr. Randy McIntosh talks about the virtual brain project (video) >
The project puts Canada in a global race to pull off a neuroscience feat that is comparable to decoding the human genome. The new funding is in addition to $7.5 million the prestigious American foundation provided five years ago to help launch the massive endeavour.
“On behalf of Baycrest and our international science team, we are energized by the continuing support and investment from the James S. McDonnell Foundation, who champion transformative research efforts,” said Dr. Randy McIntosh, project leader, senior scientist and vice-president of Research at Baycrest.
“The new funding helps our project move into its second phase and a step closer to creating a predictive modeling tool that will change the way we assess and rehabilitate brains that have suffered damage from stroke, epilepsy, or the early stages of Alzheimer’s.”
Susan Fitzpatrick, vice-president of the James S. McDonnell Foundation said “the Foundation is pleased to be able to contribute to this effort to bring cognitive neuroscience, computational biology, and clinical neurology together in an ambitious attempt to improve our abilities to alter the course of recovery for individuals with brain injuries.”
The project presents a massive informatics challenge that requires a team of scientists from Canada, the U.S., Europe and Australia to upload thousands of patterns of brain imaging data from healthy individuals and patient groups into several large super computers. Once that work is complete, the virtual brain will deliver the same observable measurements or functioning patterns as a real brain.
The implications of this new tool for clinical interventions will be revolutionary. A clinician will be able to upload brain imaging data from their patient’s unique neural architecture after a stroke, for example, into the synthetic healthy brain model to see how it responds to the disruption of normal network patterns and attempts to re-stabilize. This will assist the clinician in determining the treatment interventions that will likely have the best outcomes for their patient.
In addition to the James S. McDonnell Foundation, the Ontario Innovation Trust and Rx&D (Canada's Research-Based Pharmaceutical Companies) are supporting the project.
For Immediate Release
Baycrest’s virtual brain project receives $6.3M from American foundation
Toronto, Canada – The U.S.-based James S. McDonnell Foundation has awarded $6.3 million in new funding over the next three years to an international project led by Baycrest to create the world’s first functional, virtual brain.
Dr. Randy McIntosh, project leader.
Dr. Randy McIntosh talks about the virtual brain project (video) >
The project puts Canada in a global race to pull off a neuroscience feat that is comparable to decoding the human genome. The new funding is in addition to $7.5 million the prestigious American foundation provided five years ago to help launch the massive endeavour.
“On behalf of Baycrest and our international science team, we are energized by the continuing support and investment from the James S. McDonnell Foundation, who champion transformative research efforts,” said Dr. Randy McIntosh, project leader, senior scientist and vice-president of Research at Baycrest.
“The new funding helps our project move into its second phase and a step closer to creating a predictive modeling tool that will change the way we assess and rehabilitate brains that have suffered damage from stroke, epilepsy, or the early stages of Alzheimer’s.”
Susan Fitzpatrick, vice-president of the James S. McDonnell Foundation said “the Foundation is pleased to be able to contribute to this effort to bring cognitive neuroscience, computational biology, and clinical neurology together in an ambitious attempt to improve our abilities to alter the course of recovery for individuals with brain injuries.”
The project presents a massive informatics challenge that requires a team of scientists from Canada, the U.S., Europe and Australia to upload thousands of patterns of brain imaging data from healthy individuals and patient groups into several large super computers. Once that work is complete, the virtual brain will deliver the same observable measurements or functioning patterns as a real brain.
The implications of this new tool for clinical interventions will be revolutionary. A clinician will be able to upload brain imaging data from their patient’s unique neural architecture after a stroke, for example, into the synthetic healthy brain model to see how it responds to the disruption of normal network patterns and attempts to re-stabilize. This will assist the clinician in determining the treatment interventions that will likely have the best outcomes for their patient.
In addition to the James S. McDonnell Foundation, the Ontario Innovation Trust and Rx&D (Canada's Research-Based Pharmaceutical Companies) are supporting the project.
22.10.10
MED-IQ Organizers of CONTINUED MEDICAL EDUCATION
Programs are developed in full compliance with ACCME, OIG, and PhRMA guidelines and we guarantee every program is fair, balanced, independent, and free of commercial bias.
Team Med-IQ
Clinical content team develops programming from a participant perspective. Led by William Mencia, MD, and Rachel Karcher, PharmD, the Med-IQ team has more than 55 years of continuing medical education experience and also includes the clinical expertise of Sara Miller, MS, Allison Gardner, PhD, and Jean Cornish, RPh.
Med-IQ
5523 Research Park Drive
Suite 210
Baltimore, MD 21228
Phone: 866 858 7434
Fax: 866 419 5789
E-mail: info@med-iq.com
Team Med-IQ
Clinical content team develops programming from a participant perspective. Led by William Mencia, MD, and Rachel Karcher, PharmD, the Med-IQ team has more than 55 years of continuing medical education experience and also includes the clinical expertise of Sara Miller, MS, Allison Gardner, PhD, and Jean Cornish, RPh.
Med-IQ
5523 Research Park Drive
Suite 210
Baltimore, MD 21228
Phone: 866 858 7434
Fax: 866 419 5789
E-mail: info@med-iq.com
Subscribe to:
Posts (Atom)